Allograft Islet Cell Transplantation and Postoperatively Modified Edmonton Protocol for 3 Cases of Type 1 Diabetes Mellitus

黄孝伦,姚豫桐,罗兰云,薛华,邹海波,魏玲玲,杨卯竹,骆乐,王冠
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2014.03.009
2014-01-01
Abstract:Objective To investigate the pancreatic islet cell isolation technology,quality standards,and safety and effectiveness of allograft islet cell transplantation and modified Edmonton protocol in the treatment of type 1 diabetes (T1DM).Method Three cases of T1DM received allograft islet cell transplantation.The pancreas was taken from adult organ donation after cardiac death donor.All pancreatic organs were digested by Liberase enzyme,COBE 2991 cell separator,and discontinuous density gradient purification,to obtain high purity and high activity of islet cells.All these procedures were conducted in our GMP facilities.After culture for 12 h,testing islets reached transplant standards.After the percutaneous puncture of hepatic portal vein trunk of the recipients,islet cells were transplanted evenly through the portal vein into the liver of recipients.After islet cell transplantation,a modified Edmonton immunosuppressive protocol containing antithymocyte globulin (ATG),tacrolimus and mycophenolate mofetil was used,and the changes in blood glucose,C peptide and glycate hemoglobin were monitored regularly during a follow-up period of one year.Result The transplanted islet cells of 3 recipients were 460 00(-505 200 IEQ,and islet purity and viability were 38.5%-49.7% and 95%-97% respectively.The stimulation index of human islet was 2.8-5.4.The glucose levels of 3 recipients in the normal diet were strictly controlled below 7.8 mmol/L.Two recipients remained insulin-independent after 3-5 months.The dosage of insulin was decreased by 60% in 1 patient after 12 months.The levels of C-peptide and HbA1c were all within normal range and renal functions were improved.No complications related to islet infusion including hypoglycemia,adverse drug reactions,acute rejection and infection were observed.Conclusion Our isolation techniques and methods of islet cells are reliable.Allograft islet cell transplantation and the improved Edmonton protocol in the short-term for treatment of T1DM is safe and effective,but its long-term effect is undergoing to observe in the future.
What problem does this paper attempt to address?